Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Effect of statins in stroke prevention.

Pierre Amarenco1

  • 1Department of Neurology and Stroke Centre, Bichat University Hospital, Denis Diderot University and Medical School, Paris, France. amarenco@ccr.jussieu.fr

Current Opinion in Lipidology
|November 9, 2005
PubMed
Summary

Statin therapy shows promise in preventing major coronary events after a stroke. However, current evidence does not yet confirm its effectiveness in preventing recurrent strokes, despite lowering LDL cholesterol.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and safety of dual antiplatelet treatment up to 72 hours after mild ischemic stroke or transient ischemic attack in patients with established cardiovascular disease.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026
Same author

Dual Antiplatelet Therapy and Immediate Intensive Statin in Mild Ischemic Stroke: A Randomized Trial.

Neurology·2026
Same author

Predictors of Hematoma Expansion and Response to Andexanet in Patients With Intracerebral Hemorrhage: Secondary Analyses of the ANNEXA-I Randomized Clinical Trial.

Stroke·2026
Same author

Asundexian for Secondary Stroke Prevention.

The New England journal of medicine·2026
Same author

Prognostic Factors for Long-Term Risk of Stroke After Transient Ischemic Attack or Minor Stroke: A Systematic Review and Meta-Analysis.

Circulation·2026
Same author

Association between free fatty acid and 3-month prognosis of acute ischemic stroke.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2026

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Epidemiological studies show limited association between cholesterol and stroke.
  • Randomized trials demonstrate LDL lowering reduces stroke risk in various patient groups.
  • Meta-analyses indicate a dose-response relationship between LDL reduction and decreased stroke incidence.

Purpose of the Study:

  • To review clinical trial outcomes of statin therapy for stroke prevention and treatment.
  • To evaluate the efficacy of statins in reducing stroke risk and recurrence.

Main Methods:

  • Review of recent clinical trials on statin use in stroke.
  • Analysis of data from large-scale trials like the Heart Protection Study and SPARCL.
  • Examination of LDL cholesterol reduction as a primary mechanism of action.

Main Results:

  • Statin therapy, primarily through LDL reduction, positively impacts stroke outcomes in coronary heart disease patients.
  • Significant stroke risk reduction observed in diabetic, hypertensive, and CAD patients with statin use.
  • The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial aims to provide definitive answers on statin efficacy.

Conclusions:

  • Statin's benefit in stroke prevention is largely attributed to LDL reduction, with potential pleiotropic effects.
  • Statins are effective in preventing major coronary events post-stroke.
  • Evidence for statins preventing recurrent stroke remains inconclusive.

Related Experiment Videos